Nirogacestat - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Nirogacestat

Brand Name:

Ogsiveo

Strength:

50mg, 100mg, 150mg

HCPCS:

SEER*Rx Category:

Ancillary Therapy

Major Drug Class:

Miscellaneous Agent

Minor Drug Class:

Ɣ Secretase Inhibitor

Oral (Y/N):

Yes

FDA Approval Year:

2023

FDA Discontinuation Year:

CMS Effective Date:

CMS Discontinuation Date:

Status:

In Use